KODAK MOMENT!
Magnelibra Econemotions Deserves Some Credit No?
Hey just wanted to update everyone that missed our late day post on Kodak yesterday, well maybe we just let the chart speak for itself:
What an epic run, forget the FED today, KODAK is the news and what a great story, just goes to show you how a little govt loan goes a long way and whether or not this is the start of something great or not, it’s had an epic start that is certain.
For those that missed our post late in the trading day yesterday on it, here is what we said:
Kodak Goes Pharma!
The Wall Street Journal reported:
POTUS announced today that the old American photography company KODAK will receive a $765 million loan from the U.S. government to produce medical ingredients, including hydroxychloroquine.
(Magnelibra sent you a link to the front line doc’s yesterday, touting HCQ on the steps of the Supreme Court)
It’s the first loan of its kind under the Defense Production Act and is part of an American push to bring production back to the U.S., ending reliance on foreign sourcing.
Just for reference, Kodak was $2 two days ago, after hours trade up $3.88 to $11.82:
We hope you enjoy our work and think about subscribing to get the full trader/investor experience and enjoy the latest events that we think will matter to traders and investors.
Please continue to share our work with those that you think would benefit as we are all in this together, Cheers and good luck today traders and investors!
-Magnelibra Econemotions
DISCLAIMER: For educational purposes only. This is not a solicitation to buy or sell commodity futures or options on neither commodity futures. The risk of trading securities, futures and options can be substantial and is not for everyone. Such investments may not be appropriate for the recipient. The valuation of futures and options may fluctuate, and, as a result, clients may lose more than their original investment. Nothing contained in this message may be construed as an express or an implied promise, guarantee or implication by, of, or from the author Michael Agne owner of Magnelibra Capital Advisors. All rights are reserved. We will never claim that you will profit or that losses can or will be limited in any manner whatsoever. Past performance is not necessarily indicative of future results. Although care has been taken to assure the accuracy, completeness and reliability of the information contained herein, we make no warranty, express or implied, or assume any legal liability or responsibility for the accuracy, completeness, reliability or usefulness of any information, product, service or process disclosed.